CR Intrinsic Investors’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-344
Closed -$3.18M 391
2013
Q2
$3.18M Buy
+344
New +$3.18M 0.11% 214